Loading company…
Beijing-based biotech developing micro-droplet digital PCR systems and in vitro diagnostic reagents, founded in 2015.
Founded in 2015 and based in Beijing, China, TargetingOne is a biotech company developing micro-droplet digital PCR systems and in vitro diagnostic reagents. It sells equipment, reagents and consumables used in tumour, genetic disease and infectious disease testing, and holds more than 100 patents. In April 2024 it raised CNY 100 million in strategic investment from State-Owned Capital Operation and Management Centre of Beijing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in